Prot #TAK-007-2001: A Phase 2, Open-label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date6/10/226/10/25

Funding

  • PPD Investigator Services, LLC ((OE) Prot #TAK-007-2001 // (OE) Prot #TAK-007-2001)
  • Takeda Development Center Americas, Inc. ((OE) Prot #TAK-007-2001 // (OE) Prot #TAK-007-2001)